The North America Myomectomy Market would witness market growth of 12.9% CAGR during the forecast period (2020-2026). Myomectomy is the medical surgical method that is used to remove fibroids from the uterus without affecting the healthy tissue. Fibroids mainly develop in around 50.0% of women, and this has resulted in an increase in the demand for the methods and procedure so as to preserves the uterus, different hysterectomy. Consequently, it is considered as one of the standards of care that is capable of eliminating fibroids. This is expected to lift the market growth over the foreseeable period. Besides, the increased preference for less invasive treatment methods by the patient is likely to increase the growth of the market. These days, less invasive treatment options for the procedure comprise hysteroscopic myomectomy, and laparoscopic or robotic. All these methods are nominally invasive and there is no need for general anaesthesia. These processes cause less post-operative pain and discomfort.
The growing number of patients who are suffering from uterine fibroids and related conditions, the rising number of minimal invasive procedures, and the increasing adoption of advanced technological devices for effective and safe treatment, myomectomy procedures are adopted and they are the main factors likely to drive the market. Patients who are suffering from the problem of uterine fibroid signify a huge market growth. A myomectomy is the best effective and efficient way to treat fibroids and concurrently preserves the uterus. There are many ways to perform a myomectomical procedure and they depend on the location and size of the fibroids. According to NCBI, it is predicted that about 77.0% of women who belong to childbearing age are affected by uterine fibroids, and in about 50- 75% cases it remained asymptomatic that is why it often remains undiagnosed.
Based on Type, the market is segmented into Abdominal Myomectomy, Hysteroscopic Myomectomy and Laparoscopic Myomectomy. Based on Product, the market is segmented into Harmonic Scalpel, Laparoscopic Sealer, Laparoscopic Power Morcellators and Other Products. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: Myomectomy Market in North America is expected to register a CAGR of 12.9% during the forecast period (2020-2026)
The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Stryker Corporation, Johnson and Johnson, Hologic, Inc., Karl Storz SE & Co. KG, B. Braun Melsungen AG, ConMed Corporation, Intuitive Surgical, Inc., The Cooper Companies, Inc., and Minerva Surgical, Inc.
Market Segmentation:
By Type
By Product
By Country
Companies Profiled
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 